The use of advanced visualization software has become a necessity due to the vast image data sets produced by cardiac computed tomography (CT) and magnetic resonance imaging (MR). The technology is known for making pretty, color 3D pictures, but users say the technology goes a long way to help increase efficiency, speed diagnoses, and can guide procedures in the OR and cath lab.

Standard drug-eluting stent technology seemed to have taken a backseat at this year’s TCT as cardiologists look forward to the next-generation DES using bioresorbable polymer coatings and totally bioresorbable stents.

November 17, 2009 – The U.S. Food and Drug Administration (FDA) today warned new safety information shows an interaction between the anti-clotting medication clopidogrel (Plavix) and the proton pump inhibitor (PPI) omeprazole (Prilosec/Prilosec OTC), used to reduce stomach acid. 

November 17, 2009 – Following positive three-year data from the first 30 patients treated with a fully bioabsorbable drug-eluting coronary stent, Abbott is initiating a large-scale trial with about 1,000 patients from up to 100 centers in Europe, Asia Pacific, Canada and Latin America.

November 13, 2009 – Popular Science magazine’s “Innovation of the Year” named the 3M Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software as part of the publication’s annual “Best of What’s New Awards.”

November 13, 2009 – A 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the Harvest Technologies’ Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with nonreconstructable critical limb ischemia (CLI) has completed enrollment.

November 13, 2009 – Microvolt T-Wave Alternans (MTWA) technology from Cambridge Heart Inc. will be incorporated into a new module being developed for Cardiac Science’s cardiac stress test systems.

November 13, 2009 – A new study, published in the Nov. 17, 2009 issue of the Journal of the American College of Cardiology, adds to a growing body of research seeking to evaluate and understand possible sex differences associated with anti-platelet therapies.

November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo will be released at the American Heart Association meeting in Orlando this weekend.

November 12, 2009 - To achieve the HITECH Act's goal of improving healthcare for patients by making it patient-centered, "information should follow the patient, and... should not get in the way," stressed David Blumenthal, M.D., M.P.P., the national coordinator for health information technology, U.S. Department of Health & Human Services, in a public statement issued today.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now